Suven Life Sciences Announces 37th AGM on August 25, 2026
Suven Life Sciences Ltd has announced its 37th Annual General Meeting (AGM) to be held on Tuesday, August 25, 2026, at 11:30 a.m. IST via Video Conference (VC) / Other Audio Visual Means (OAVM). The AGM will transact ordinary business including the adoption of audited standalone and consolidated financial statements for the financial year ended March 31, 2026, and the re-appointment of Prof. Seyed E Hasnain as a Director. Special business includes approving a related party transaction for the appointment of Dr. Madhavi Jasti to an office or place of profit in overseas wholly-owned subsidiaries, with an initial annual remuneration of USD 400,000, potentially revised up to USD 1,000,000. Remote e-voting is available from August 21 to August 24, 2026.
Key Highlights
- AGM scheduled for August 25, 2026, via VC/OAVM.
- Adoption of FY26 financial statements and Director re-appointment on agenda.
- Approval sought for Dr. Madhavi Jasti's overseas role with remuneration.
- E-voting period: August 21-24, 2026.
- Annual Report available on company website.
Price Impact
More from SUVEN